Hogan Lovells US

Hogan Lovells US operates as a global megafirm, co-headquartered in London and Washington, D.C., with a significant international footprint of over 35 offices across the United States, Europe, Latin America, Asia, and the Middle East. The firm boasts a substantial legal team of more than 2,800 lawyers. It consistently ranks among the top legal firms, holding the #30 position on the Vault Law 100 and #12 on the AmLaw ranking of highest-grossing U.S. law firms. The firm is set to merge with Cadwalader, Wickersham & Taft on July 1, 2026, which would establish it as the fifth-largest law firm globally.

Hogan Lovells' Intellectual Property practice handles high-stakes disputes across patents, trademarks, trade secrets, and copyright, emphasizing both technical depth and global reach. Their patent litigation experience spans a broad range of industries, including life sciences, chemical, high-tech, electronics, medical devices, information and communication technology, and automotive. The firm's case experience, as tracked, includes patent defense for technology giants like Microsoft Corporation and Google LLC in cases brought by VirtaMove Corp., and Mercedes-Benz AG against Mimzi, LLC. The firm also represented Samsung Electronics Co., Ltd. as a plaintiff against Netlist, Inc.

The firm primarily defends operating companies in patent litigation, with three out of its four tracked appearances being on the defendant side. This aligns with their focus on advising global brands and emerging disruptors in protecting their intellectual property. Notable partners in the firm's global IP litigation practice include Paul Brown, head of patents in London and a specialist in electronics and medical devices, particularly standard-essential patents (SEPs) and FRAND obligations, and Dr. Andreas von Falck in Düsseldorf, known for his work in life sciences, chemical, and high-tech industries.

Hogan Lovells possesses a notable practice in Patent Trial and Appeal Board (PTAB) and inter partes review (IPR) proceedings, particularly within the pharmaceutical, biotechnological, and medical device sectors. They advise clients on the advantages of AIA adversarial proceedings over traditional federal court litigation for challenging patents, highlighting faster resolution, lower costs, and technically trained judges. The firm actively engages in IPRs, post-grant reviews (PGRs), and covered business method (CBM) patent challenges. Key US-based IP litigation partners include Celine Jimenez Crowson, Joseph J. Raffetto, Matthew Gibson, Connor L. Day, David A. Perlson, Antonio Sistos, and Jason D. Lohr, who have been involved in the firm's tracked cases.